Giornale italiano di cardiologia (2006) · 2023
[Pulmonary hypertension clinical pathway: ANMCO Tuscany Board model].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Spaziani Gaia, Monti Simonetta, Misuraca Leonardo, Airò Edoardo, Traini Anna Maria, Bauleo Carolina, Canale Maria Laura, Carluccio Marisa, Grippo Gabriele, Selvaggia Magnaghi Gaia Chiara, Orso Francesco, Sorini Dini Carlotta, Talini Enrica, Poddighe Rosa, Picchi Andrea, Limbruno Ugo, Favilli Silvia, Casolo Giancarlo, a nome della Sezione Regionale ANMCO Toscana
Аннотация
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure >20 mmHg at rest during right heart catheterization. PH prevalence is about 1% of the global population. The PH clinical classification includes five groups: pulmonary arterial hypertension, PH associated with left heart disease, PH associated with lung disease, PH associated with pulmonary artery obstructions, PH with unclear and/or multifactorial mechanisms. In case of clinical suspicion, echocardiography is the first-line tool to start the diagnostic process. Right heart catheterization is the gold standard for diagnosis of PH, requires great experience and should be performed in expert centers. The classification of the PH patient in a specific subgroup requires multidisciplinary clinical and instrumental skills that only a reference center can provide. This document proposes a clinical pathway for the management of PH patients in the Tuscany region in order to standardize access to specialized care.